Related Experiment Video
Updated: Apr 16, 2026
Photodynamic Therapy with Blended Conducting Polymer/Fullerene Nanoparticle Photosensitizers
Published on: October 28, 2015
Enhanced photodynamic therapy efficacy of methylene blue-loaded calcium phosphate nanoparticles
Da-Young Seong1, Young-Jin Kim1
1Department of Biomedical Engineering, Catholic University of Daegu, Gyeongsan 712-702, Republic of Korea.
Abstract:
Although methylene blue (MB) is the most inexpensive photosensitizer with promising applications in the photodynamic therapy (PDT) for its high quantum yield of singlet oxygen generation, the clinical use of MB has been limited by its rapid enzymatic reduction in the biological environment. To enhance PDT efficacy of MB by preventing the enzymatic reduction, we have developed a new mineralization method to produce highly biocompatible MB-loaded calcium phosphate (CaP-MB) nanoparticles in the presence of polymer templates. The resulting CaP-MB nanoparticles exhibited spherical shape with a size of under 50 nm. Fourier transform infrared (FT-IR) and zeta-potential analyses confirmed the insertion of MB into the CaP-MB nanoparticles. The encapsulation of MB in CaP nanoparticles could effectively protect MB from the enzymatic reduction. In addition, the CaP-MB nanoparticles exhibited a good biocompatibility in the dark condition and significantly enhanced PDT efficacy due to apoptotic cell death against human breast cancer cells as compared with free MB, implying that CaP-MB nanoparticle system might be potentially applicable in PDT.
Insights
Researchers developed methylene blue-loaded calcium phosphate nanoparticles to improve photodynamic therapy (PDT). This novel nanoparticle system protects methylene blue from degradation, enhancing its cancer-fighting efficacy and biocompatibility for potential clinical use.
Area of Science:
- Biomaterials Science
- Nanotechnology
- Photodynamic Therapy
Background:
- Methylene blue (MB) is an inexpensive photosensitizer with high singlet oxygen generation, suitable for photodynamic therapy (PDT).
- Clinical application of MB is hindered by its rapid enzymatic reduction in biological systems.
- Developing strategies to protect MB is crucial for enhancing PDT efficacy.
Purpose of the Study:
- To develop a novel method for producing biocompatible methylene blue-loaded calcium phosphate (CaP-MB) nanoparticles.
- To enhance the stability and efficacy of MB for photodynamic therapy (PDT).
- To evaluate the biocompatibility and anti-cancer effects of the developed CaP-MB nanoparticles.
Main Methods:
- A mineralization method using polymer templates was employed to synthesize CaP-MB nanoparticles.
- Nanoparticle characterization included size analysis, Fourier transform infrared (FT-IR), and zeta-potential measurements.
- In vitro studies assessed MB release, enzymatic stability, biocompatibility, and PDT efficacy against human breast cancer cells.
Main Results:
- Spherical CaP-MB nanoparticles under 50 nm were successfully synthesized.
- FT-IR and zeta-potential analyses confirmed successful MB encapsulation within the CaP nanoparticles.
- CaP-MB nanoparticles protected MB from enzymatic degradation, showed good biocompatibility, and significantly enhanced PDT-induced apoptotic cell death in cancer cells compared to free MB.
Conclusions:
- The developed CaP-MB nanoparticle system effectively protects methylene blue from enzymatic reduction.
- CaP-MB nanoparticles demonstrate enhanced biocompatibility and superior photodynamic therapy efficacy against human breast cancer cells.
- This CaP-MB nanoparticle system holds significant potential for future clinical applications in PDT.
